p53 regulates myogenesis by triggering the differentiation activity of pRb

Journal of Cell Biology

Volumn 151, Issue 6, 2000, Pages 1295-1303

  Porrello, Alessandro ^a   Cerone, Maria Antonietta ^a   Coen, Sabrina ^a   Gurtner, Aymone ^a   Fontemaggi, Giulia ^a   Cimino, Letizia ^a   Piaggio, Giulia ^a   Sacchi, Ada ^a   Soddu, Silvia ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Differentiation; Muscle; MyoD; p53; Rb

Indexed keywords

CELL CYCLE PROTEIN; MYOD PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CYCLE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REACTION ANALYSIS; SKELETAL MUSCLE;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; MICE; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTORS; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA PROTEIN; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

ANIMALIA;

EID: 0034638841     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.151.6.1295     Document Type: Article

References (54)

1. Involvement of p53 in cell differentiation and development
2. Testicular tissue-specific expression of the p53 suppressor gene
3. High-frequency developmental abnormalities in p53-deficient mice
4. Inhibition of cell proliferation by an adenovirus vector expressing the human wild type p53 protein
5. Immunochemical analyses of myosin heavy chain during avian myogenesis in vivo and in vitro
6. Development of a murine orthotopic model of leukemia: Evaluation of TP53 gene therapy efficacy
7. c-Myc target gene specificity is determined by a post-DNA-binding mechanism
8. p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts
9. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product
10. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6
11. p53 in embryonic development: Maintaining a fine balance
12. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: Mechanisms of phenotypic correction in mixed culture with normal cells
13. Cell cycle reactivation in terminally differentiated cells by adenovirus infection
14. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53
15. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells
16. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
17. p53 dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
18. Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated with undifferentiated thyroid cancers
19. p53 in chronic myelogenous leukemia in acute phase
20. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
21. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
22. Levels of p53 protein increase with maturation in human hematopoietic cells
23. The emerging p53 gene family
24. p53, the cellular gatekeeper for growth and division
25. MyoD induces retinoblastoma gene expression during myogenic differentiation
26. Displacement of sequence-specific transcription factors from mitotic chromatin
27. The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells
28. Defining the regulatory networks for muscle development
29. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53
30. p63 is a p53 homologue required for limb and epidermal morphogenesis
31. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
32. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
33. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle
34. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation
35. ATF site of human RB gene promoter is a responsive element of myogenic differentiation
36. Lonely no more: p53 finds its kin in a tumor suppressor haven
37. Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter
38. p53-independent expression of p21(Cip1) in muscle and other terminally differentiating cells
39. A subset of p53-deficient embryos exhibits exencephaly
40. Expression of p53 during mouse embryogenesis
41. Reversal of terminal differentiation mediated by p107 in Rb(-/-) muscle cells
42. Stable binding of E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
43. Interference with p53 protein inhibits hemopoietic and muscle differentiation
44. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene
45. p53 activity is essential for normal development in Xenopus
46. The retinoblastoma protein and the cell cycle control
47. The MyoD gene family: Nodal point during specification of the muscle cell lineage
48. Target gene specificity of E2F and pocket protein family members in living cells
49. Muscle basic helix-loop-helix proteins and the regulation of myogenesis
50. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
51. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumors
52. Skeletal muscle determination and differentiation: Story of a core regulatory network and its context
53. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays